![](https://geistlich.us/wp-content/uploads/clinical-case-bg.jpg)
CLINICAL CASE
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_1.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_2.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_3.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_4.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_5.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_6.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_7.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_8.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_9.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_10.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_11.jpg)
![](https://geistlich.us/wp-content/uploads/1-chiapasco-casentini_12.jpg)
Download our new eBook and learn how to 4C predictability
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
Geistlich unveils vallos®, a full line of allograft granules and fibers. Discover vallos®